Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2024

Open Access 01-12-2024 | Type 2 Diabetes | Research

Effect of intermittent fasting on lipid biokinetics in obese and overweight patients with type 2 diabetes mellitus: prospective observational study

Authors: Yasmin Atwa Mohamed, Megahed Abouelmagd, Aya Elbialy, Mona Elwassefy, Fady Kyrillos

Published in: Diabetology & Metabolic Syndrome | Issue 1/2024

Login to get access

Abstract

Background

Intermittent fasting (IF) is a commonly used dietary practice that alternates between periods of unrestricted dietary consumption and abstinence from caloric intake. IF reduces caloric intake along with metabolic switch from utilization of glucose to fatty acids and ketones and resulting in reduction in adiposity and subsequently insulin resistance. Thus, it has been hypothesized that IF regimens can improve body composition in obese and overweight individuals.

Aim

To assess the effect of IF on lipid biokinetics in obese and overweight patients with type 2 diabetes (T2D).

Patients and methods

Thirty overweight or obese T2D patients were recruited from the diabetes outpatient clinics at the Specialized Medical Hospital, Mansoura University. Patients were subjected to time restricted fasting for 16 h (from dawn to sunset) during Ramadan. Anthropometric data were measured for participants before and 3 weeks after Ramadan fasting. Fasting plasma glucose (FPG), HbA1c, lipid profile, leptin, beta hydroxybutyrate (βHB) and high sensitive CRP levels were measured 1 week before and 3 weeks after Ramadan fasting.

Results

30 diabetic patients were recruited with a mean age of 54.3 ± 7.2 years. 24 (80%) were females. Obesity was diagnosed in 27 cases (90%). The median diabetes duration was 10 years. The study showed a statistically significant decrease in post-fasting body weight (BW), Body mass index (BMI), waist circumference (WC) & hip circumference (HC). There was a statistically significant decrease of post-fasting low density lipoprotein (LDL-C), Total cholesterol (TC), and leptin. The study also showed a statistically significant increase of post-fasting high density lipoprotein (HDL-C) and βHB. No significant change was found in post-fasting levels of HbA1c, FPG, triglycerides (TG) or high sensitive CRP. Post-fasting leptin was positively correlated with post-fasting BW, BMI, WC, and HC. Post-fasting βHB was positively correlated with post-fasting TG, HbA1c, and LDL-C. Leptin levels change (pre vs post fasting) was positively correlated with the change in LDL-C levels.

Conclusion

IF reduced leptin and increased β-hydroxybutyrate levels. IF is an effective tool for losing weight and visceral fat and improving lipid profile in obese and overweight patients with T2D.
Literature
1.
go back to reference Abdullah K, Al-Habori M, Al-Eryani E. Ramadan intermittent fasting affects adipokines and leptin/adiponectin ratio in type 2 diabetes mellitus and their first-degree relatives. Hindawi BioMed Res Int. 2020;2020:1.CrossRef Abdullah K, Al-Habori M, Al-Eryani E. Ramadan intermittent fasting affects adipokines and leptin/adiponectin ratio in type 2 diabetes mellitus and their first-degree relatives. Hindawi BioMed Res Int. 2020;2020:1.CrossRef
2.
go back to reference Ahmed N, Farooq J, Siddiqi HS, Meo SA, Kulsoom B, Laghari AH, Jamshed H, Pasha F. Impact of intermittent fasting on lipid profile–a quasi-randomized clinical trial. Front Nutr. 2021;7: 596787.PubMedPubMedCentralCrossRef Ahmed N, Farooq J, Siddiqi HS, Meo SA, Kulsoom B, Laghari AH, Jamshed H, Pasha F. Impact of intermittent fasting on lipid profile–a quasi-randomized clinical trial. Front Nutr. 2021;7: 596787.PubMedPubMedCentralCrossRef
3.
go back to reference Albosta M, Bakke J. Intermittent fasting: is there a role in the treatment of diabetes? A review of the literature and guide for primary care physicians. Clinical diabetes and endocrinology. 2021;7(1):1–12.CrossRef Albosta M, Bakke J. Intermittent fasting: is there a role in the treatment of diabetes? A review of the literature and guide for primary care physicians. Clinical diabetes and endocrinology. 2021;7(1):1–12.CrossRef
4.
go back to reference Al-Rawi N, Madkour M, Jahrami H, Salahat D, Alhasan F, BaHammam A, Al-Islam Faris ME. Effect of diurnal intermittent fasting during Ramadan on ghrelin, leptin, melatonin, and cortisol levels among overweight and obese subjects: a prospective observational study. PLoS ONE. 2020;15(8): e0237922.PubMedPubMedCentralCrossRef Al-Rawi N, Madkour M, Jahrami H, Salahat D, Alhasan F, BaHammam A, Al-Islam Faris ME. Effect of diurnal intermittent fasting during Ramadan on ghrelin, leptin, melatonin, and cortisol levels among overweight and obese subjects: a prospective observational study. PLoS ONE. 2020;15(8): e0237922.PubMedPubMedCentralCrossRef
5.
go back to reference Antoni R, Johnston KL, Collins AL, Robertson MD. Intermittent v. continuous energy restriction: differential effects on postprandial glucose and lipid metabolism following matched weight loss in overweight/obese participants. Br J Nutr. 2018;119(5):507–16.PubMedCrossRef Antoni R, Johnston KL, Collins AL, Robertson MD. Intermittent v. continuous energy restriction: differential effects on postprandial glucose and lipid metabolism following matched weight loss in overweight/obese participants. Br J Nutr. 2018;119(5):507–16.PubMedCrossRef
6.
go back to reference Bahijri S, Borai A, Ajabnoor G, Abdul Khaliq A, AlQassas I, Al-Shehri D, Chrousos G. Relative metabolic stability, but disrupted circadian cortisol secretion during the fasting month of Ramadan. PLoS One. 2013;8(4): e60917.PubMedPubMedCentralCrossRef Bahijri S, Borai A, Ajabnoor G, Abdul Khaliq A, AlQassas I, Al-Shehri D, Chrousos G. Relative metabolic stability, but disrupted circadian cortisol secretion during the fasting month of Ramadan. PLoS One. 2013;8(4): e60917.PubMedPubMedCentralCrossRef
7.
go back to reference Banks WA. Role of the blood–brain barrier in the evolution of feeding and cognition. Ann NY Acad Sci. 2012;1264(1):13–9.PubMedCrossRef Banks WA. Role of the blood–brain barrier in the evolution of feeding and cognition. Ann NY Acad Sci. 2012;1264(1):13–9.PubMedCrossRef
8.
go back to reference Barkia A, Mohamed K, Smaoui M, Zouari N, Hammami M, Nasri M. Change of diet, plasma lipids, lipoproteins, and fatty acids during Ramadan: a controversial association of the considered Ramadan model with atherosclerosis risk. J Health Popul Nutr. 2011;29(5):486.PubMedPubMedCentralCrossRef Barkia A, Mohamed K, Smaoui M, Zouari N, Hammami M, Nasri M. Change of diet, plasma lipids, lipoproteins, and fatty acids during Ramadan: a controversial association of the considered Ramadan model with atherosclerosis risk. J Health Popul Nutr. 2011;29(5):486.PubMedPubMedCentralCrossRef
9.
go back to reference Bassuk SS, Rifai N, Ridker PM. High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol. 2004;29(8):439–93.PubMed Bassuk SS, Rifai N, Ridker PM. High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol. 2004;29(8):439–93.PubMed
10.
go back to reference Bouassida A, Chamari K, Zaouali M, Feki Y, Zbidi A, Tabka Z. Review on leptin and adiponectin responses and adaptations to acute and chronic exercise. Br J Sports Med. 2010;44(9):620–30.PubMedCrossRef Bouassida A, Chamari K, Zaouali M, Feki Y, Zbidi A, Tabka Z. Review on leptin and adiponectin responses and adaptations to acute and chronic exercise. Br J Sports Med. 2010;44(9):620–30.PubMedCrossRef
11.
go back to reference Catenacci VA, Pan Z, Ostendorf D, Brannon S, Gozansky WS, Mattson MP, Martin B, MacLean PS, Melanson EL, Troy Donahoo W. A randomized pilot study comparing zero-calorie alternate-day fasting to daily caloric restriction in adults with obesity. Obesity. 2016;24(9):1874–83.PubMedCrossRef Catenacci VA, Pan Z, Ostendorf D, Brannon S, Gozansky WS, Mattson MP, Martin B, MacLean PS, Melanson EL, Troy Donahoo W. A randomized pilot study comparing zero-calorie alternate-day fasting to daily caloric restriction in adults with obesity. Obesity. 2016;24(9):1874–83.PubMedCrossRef
12.
go back to reference Cerniuc C, Fischer T, Baumeister A, Bordewick Dell U. Impact of intermittent fasting (5: 2) on ketone body production in healthy female subjects. Ernährungs Umschau. 2019;66(1):2–9. Cerniuc C, Fischer T, Baumeister A, Bordewick Dell U. Impact of intermittent fasting (5: 2) on ketone body production in healthy female subjects. Ernährungs Umschau. 2019;66(1):2–9.
13.
go back to reference Chan JL, Heist K, DePaoli AM, Veldhuis JD, Mantzoros CS. The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J Clin Investig. 2003;111(9):1409–21.PubMedPubMedCentralCrossRef Chan JL, Heist K, DePaoli AM, Veldhuis JD, Mantzoros CS. The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J Clin Investig. 2003;111(9):1409–21.PubMedPubMedCentralCrossRef
14.
go back to reference Cho Y, Hong N, Kim KW, Cho SJ, Lee M, Lee YH, Kang BS, Cha BS, Lee BW. The effectiveness of intermittent fasting to reduce body mass index and glucose metabolism: a systematic review and meta-analysis. J Clin Med. 2019;8(10):1645.PubMedPubMedCentralCrossRef Cho Y, Hong N, Kim KW, Cho SJ, Lee M, Lee YH, Kang BS, Cha BS, Lee BW. The effectiveness of intermittent fasting to reduce body mass index and glucose metabolism: a systematic review and meta-analysis. J Clin Med. 2019;8(10):1645.PubMedPubMedCentralCrossRef
15.
go back to reference Combs TP, Wagner JA, Berger J, Doebber T, Wang WJ, Zhang BB, Tanen M, Berg AH, O’Rahilly S, Savage DB, Chatterjee K. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARγ agonists: a potential mechanism of insulin sensitization. Endocrinology. 2002;143(3):998–1007.PubMedCrossRef Combs TP, Wagner JA, Berger J, Doebber T, Wang WJ, Zhang BB, Tanen M, Berg AH, O’Rahilly S, Savage DB, Chatterjee K. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARγ agonists: a potential mechanism of insulin sensitization. Endocrinology. 2002;143(3):998–1007.PubMedCrossRef
16.
go back to reference De Cabo R, Mattson MP. Effects of intermittent fasting on health, aging, and disease. N Engl J Med. 2019;381(26):2541–51.PubMedCrossRef De Cabo R, Mattson MP. Effects of intermittent fasting on health, aging, and disease. N Engl J Med. 2019;381(26):2541–51.PubMedCrossRef
17.
go back to reference DiNicolantonio JJ, McCarty M. Autophagy-induced degradation of Notch1, achieved through intermittent fasting, may promote beta cell neogenesis: implications for reversal of type 2 diabetes. Open Heart. 2019;6(1): e001028.PubMedPubMedCentralCrossRef DiNicolantonio JJ, McCarty M. Autophagy-induced degradation of Notch1, achieved through intermittent fasting, may promote beta cell neogenesis: implications for reversal of type 2 diabetes. Open Heart. 2019;6(1): e001028.PubMedPubMedCentralCrossRef
18.
go back to reference Dong TA, Sandesara PB, Dhindsa DS, Mehta A, Arneson LC, Dollar AL, Taub PR, Sperling LS. Intermittent fasting: a heart healthy dietary pattern? Am J Med. 2020;133(8):901–7.PubMedPubMedCentralCrossRef Dong TA, Sandesara PB, Dhindsa DS, Mehta A, Arneson LC, Dollar AL, Taub PR, Sperling LS. Intermittent fasting: a heart healthy dietary pattern? Am J Med. 2020;133(8):901–7.PubMedPubMedCentralCrossRef
19.
go back to reference Fasshauer M, Klein J, Kralisch S, Klier M, Lössner U, Blüher M, Paschke R. Growth hormone is a positive regulator of adiponectin receptor 2 in 3T3-L1 adipocytes. FEBS Lett. 2004;558(1–3):27–32.PubMedCrossRef Fasshauer M, Klein J, Kralisch S, Klier M, Lössner U, Blüher M, Paschke R. Growth hormone is a positive regulator of adiponectin receptor 2 in 3T3-L1 adipocytes. FEBS Lett. 2004;558(1–3):27–32.PubMedCrossRef
20.
go back to reference Faul F, Erdfelder E, Lang A-G, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175–91.PubMedCrossRef Faul F, Erdfelder E, Lang A-G, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175–91.PubMedCrossRef
21.
go back to reference Faul F, Erdfelder E, Buchner A, Lang A-G. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41:1149–60.PubMedCrossRef Faul F, Erdfelder E, Buchner A, Lang A-G. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41:1149–60.PubMedCrossRef
22.
go back to reference Gaeini Z, Mirmiran P, Bahadoran Z. Effects of Ramadan intermittent fasting on leptin and adiponectin: a systematic review and meta-analysis. Hormones. 2021;20(2):237–46.PubMedCrossRef Gaeini Z, Mirmiran P, Bahadoran Z. Effects of Ramadan intermittent fasting on leptin and adiponectin: a systematic review and meta-analysis. Hormones. 2021;20(2):237–46.PubMedCrossRef
24.
go back to reference Harvie MN, Pegington M, Mattson MP, et al. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes. 2011;35(5):714–27.CrossRef Harvie MN, Pegington M, Mattson MP, et al. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes. 2011;35(5):714–27.CrossRef
25.
go back to reference Henry RR, Gumbiner B, Ditzler T, Wallace P, Lyon R, Glauber HS. Intensive conventional insulin therapy for type II diabetes: metabolic effects during a 6-mo outpatient trial. Diabetes Care. 1993;16(1):21–31.PubMedCrossRef Henry RR, Gumbiner B, Ditzler T, Wallace P, Lyon R, Glauber HS. Intensive conventional insulin therapy for type II diabetes: metabolic effects during a 6-mo outpatient trial. Diabetes Care. 1993;16(1):21–31.PubMedCrossRef
26.
go back to reference Huang AW, Wei M, Caputo S, Wilson ML, Antoun J, Hsu WC. An intermittent fasting mimicking nutrition bar extends physiologic ketosis in time restricted eating: a randomized, controlled, parallel-arm study. Nutrients. 2021;13(5):1523.PubMedPubMedCentralCrossRef Huang AW, Wei M, Caputo S, Wilson ML, Antoun J, Hsu WC. An intermittent fasting mimicking nutrition bar extends physiologic ketosis in time restricted eating: a randomized, controlled, parallel-arm study. Nutrients. 2021;13(5):1523.PubMedPubMedCentralCrossRef
27.
go back to reference Katz EG, Stevens J, Truesdale KP, Cai J, Adair LS, North KE. Hip circumference and incident metabolic risk factors in Chinese men and women: the People’s Republic of China study. Metab Syndr Relat Disord. 2011;9(1):55–62.PubMedPubMedCentralCrossRef Katz EG, Stevens J, Truesdale KP, Cai J, Adair LS, North KE. Hip circumference and incident metabolic risk factors in Chinese men and women: the People’s Republic of China study. Metab Syndr Relat Disord. 2011;9(1):55–62.PubMedPubMedCentralCrossRef
28.
go back to reference Keys A, Fidanza F, Karvonen MJ, Kimura N, Taylor HL. Indices of relative weight and obesity. J Chronic Dis. 1972;25(6–7):329–43.PubMedCrossRef Keys A, Fidanza F, Karvonen MJ, Kimura N, Taylor HL. Indices of relative weight and obesity. J Chronic Dis. 1972;25(6–7):329–43.PubMedCrossRef
29.
go back to reference Khedkar PH. Intermittent fasting—the new lifestyle? Acta Physiol. 2020;229(4): e13518.CrossRef Khedkar PH. Intermittent fasting—the new lifestyle? Acta Physiol. 2020;229(4): e13518.CrossRef
30.
go back to reference Kord HV, Tinsley GM, Santos HO, Zand H, Nazary A, Fatahi S, Mokhtari Z, Salehi-sahlabadi A, Tan SC, Rahmani J, Gaman MA, Sathian B, Sadeghi A, Hatami B, Soltanieh S, Aghamiri S, Bawadi H, Hekmatdoost A, Hekmatdoost A. The influence of fasting and energy-restricted diets on leptin and adiponectin levels in humans: a systematic review and meta-analysis. Clin Nutr. 2021;40(4):1811–21.CrossRef Kord HV, Tinsley GM, Santos HO, Zand H, Nazary A, Fatahi S, Mokhtari Z, Salehi-sahlabadi A, Tan SC, Rahmani J, Gaman MA, Sathian B, Sadeghi A, Hatami B, Soltanieh S, Aghamiri S, Bawadi H, Hekmatdoost A, Hekmatdoost A. The influence of fasting and energy-restricted diets on leptin and adiponectin levels in humans: a systematic review and meta-analysis. Clin Nutr. 2021;40(4):1811–21.CrossRef
31.
go back to reference Kotarsky CJ, Johnson NR, Mahoney SJ, Mitchell SL, Schimek RL, Stastny SN, Hackney KJ. Time-restricted eating and concurrent exercise training reduces fat mass and increases lean mass in overweight and obese adults. Physiol Rep. 2021;9(10): e14868.PubMedPubMedCentralCrossRef Kotarsky CJ, Johnson NR, Mahoney SJ, Mitchell SL, Schimek RL, Stastny SN, Hackney KJ. Time-restricted eating and concurrent exercise training reduces fat mass and increases lean mass in overweight and obese adults. Physiol Rep. 2021;9(10): e14868.PubMedPubMedCentralCrossRef
32.
go back to reference López-Jaramillo P, Gómez-Arbeláez D, López-López J, López-López C, Martínez-Ortega J, Gómez-Rodríguez A, Triana-Cubillos S. The role of leptin/adiponectin ratio in metabolic syndrome and diabetes. Horm Mol Biol Clin Invest. 2014;18(1):37–45. López-Jaramillo P, Gómez-Arbeláez D, López-López J, López-López C, Martínez-Ortega J, Gómez-Rodríguez A, Triana-Cubillos S. The role of leptin/adiponectin ratio in metabolic syndrome and diabetes. Horm Mol Biol Clin Invest. 2014;18(1):37–45.
33.
go back to reference Mars M, de Graaf C, de Groot LC, Kok FJ. Decreases in fasting leptin and insulin concentrations after acute energy restriction and subsequent compensation in food intake. Am J Clin Nutr. 2005;81(3):570–7.PubMedCrossRef Mars M, de Graaf C, de Groot LC, Kok FJ. Decreases in fasting leptin and insulin concentrations after acute energy restriction and subsequent compensation in food intake. Am J Clin Nutr. 2005;81(3):570–7.PubMedCrossRef
34.
go back to reference Martin SS, Qasim AN, Rader DJ, Reilly MP. C-reactive protein modifies the association of plasma leptin with coronary calcium in asymptomatic overweight individuals. Obesity. 2012;20(4):856–61.PubMedCrossRef Martin SS, Qasim AN, Rader DJ, Reilly MP. C-reactive protein modifies the association of plasma leptin with coronary calcium in asymptomatic overweight individuals. Obesity. 2012;20(4):856–61.PubMedCrossRef
35.
go back to reference Mattson MP, Moehl K, Ghena N, Schmaedick M, Cheng A. Intermittent metabolic switching, neuroplasticity and brain health. Nat Rev Neurosci. 2018;19(2):81–94.CrossRef Mattson MP, Moehl K, Ghena N, Schmaedick M, Cheng A. Intermittent metabolic switching, neuroplasticity and brain health. Nat Rev Neurosci. 2018;19(2):81–94.CrossRef
36.
go back to reference Mindikoglu AL, Abdulsada MM, Jain A, Choi JM, Jalal PK, Devaraj S, Mezzari MP, Petrosino JF, Opekun AR, Jung SY, Jung SY. Intermittent fasting from dawn to sunset for 30 consecutive days is associated with anticancer proteomic signature and upregulates key regulatory proteins of glucose and lipid metabolism, circadian clock, DNA repair, cytoskeleton remodeling, immune system and cognitive function in healthy subjects. J Proteomics. 2020;217: 103645.PubMedPubMedCentralCrossRef Mindikoglu AL, Abdulsada MM, Jain A, Choi JM, Jalal PK, Devaraj S, Mezzari MP, Petrosino JF, Opekun AR, Jung SY, Jung SY. Intermittent fasting from dawn to sunset for 30 consecutive days is associated with anticancer proteomic signature and upregulates key regulatory proteins of glucose and lipid metabolism, circadian clock, DNA repair, cytoskeleton remodeling, immune system and cognitive function in healthy subjects. J Proteomics. 2020;217: 103645.PubMedPubMedCentralCrossRef
37.
go back to reference Minokoshi Y, Toda C, Okamoto S. Regulatory role of leptin in glucose and lipid metabolism in skeletal muscle. Indian J Endocrinol Metabol. 2012;16(Suppl 3):S562–8.CrossRef Minokoshi Y, Toda C, Okamoto S. Regulatory role of leptin in glucose and lipid metabolism in skeletal muscle. Indian J Endocrinol Metabol. 2012;16(Suppl 3):S562–8.CrossRef
38.
go back to reference Morioka T, Mori K, Motoyama K, Emoto M. Ectopic fat accumulation and glucose homeostasis: role of leptin in glucose and lipid metabolism and mass maintenance in skeletal muscle. In Musculoskeletal Disease Associated with Diabetes Mellitus (pp. 201–213). 2016; Springer, Tokyo. Morioka T, Mori K, Motoyama K, Emoto M. Ectopic fat accumulation and glucose homeostasis: role of leptin in glucose and lipid metabolism and mass maintenance in skeletal muscle. In Musculoskeletal Disease Associated with Diabetes Mellitus (pp. 201–213). 2016; Springer, Tokyo.
39.
go back to reference Motoshima H, Wu X, Sinha MK, Hardy VE, Rosato EL, Barbot DJ, Rosato FE, Goldstein BJ. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab. 2002;87(12):5662–7.PubMedCrossRef Motoshima H, Wu X, Sinha MK, Hardy VE, Rosato EL, Barbot DJ, Rosato FE, Goldstein BJ. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab. 2002;87(12):5662–7.PubMedCrossRef
40.
go back to reference Münzberg H, Myers MG Jr. Molecular and anatomical determinants of central leptin resistance. Nat Neurosci. 2005;8(5):566–70.PubMedCrossRef Münzberg H, Myers MG Jr. Molecular and anatomical determinants of central leptin resistance. Nat Neurosci. 2005;8(5):566–70.PubMedCrossRef
41.
go back to reference Papamichou D, Panagiotakos DB, Itsiopoulos C. Dietary patterns and management of type 2 diabetes: A systematic review of randomised clinical trials. Nutr Metab Cardiovasc Dis. 2019;29(6):531–43.PubMedCrossRef Papamichou D, Panagiotakos DB, Itsiopoulos C. Dietary patterns and management of type 2 diabetes: A systematic review of randomised clinical trials. Nutr Metab Cardiovasc Dis. 2019;29(6):531–43.PubMedCrossRef
42.
go back to reference Park JS, Cho MH, Nam JS, et al. Visceral adiposity and leptin are independently associated with C-reactive protein in Korean type 2 diabetic patients. Acta Diabetol. 2010;47:113–8.PubMedCrossRef Park JS, Cho MH, Nam JS, et al. Visceral adiposity and leptin are independently associated with C-reactive protein in Korean type 2 diabetic patients. Acta Diabetol. 2010;47:113–8.PubMedCrossRef
43.
go back to reference Radhakishun N, Blokhuis C, van Vliet M, von Rosenstiel I, Weijer O, Heymans M, Beijnen J, Brandjes D, Diamant M. Intermittent fasting during Ramadan causes a transient increase in total, LDL, and HDL cholesterols and hs-CRP in ethnic obese adolescents. Eur J Pediatr. 2014;173(8):1103–6.PubMed Radhakishun N, Blokhuis C, van Vliet M, von Rosenstiel I, Weijer O, Heymans M, Beijnen J, Brandjes D, Diamant M. Intermittent fasting during Ramadan causes a transient increase in total, LDL, and HDL cholesterols and hs-CRP in ethnic obese adolescents. Eur J Pediatr. 2014;173(8):1103–6.PubMed
44.
45.
go back to reference Saito K, Tobe T, Yoda M, Nakano Y, Choi-Miura NH, Tomita M. Regulation of gelatin-binding protein 28 (GBP28) gene expression by C/EBP. Biol Pharm Bull. 1999;22(11):1158–62.PubMedCrossRef Saito K, Tobe T, Yoda M, Nakano Y, Choi-Miura NH, Tomita M. Regulation of gelatin-binding protein 28 (GBP28) gene expression by C/EBP. Biol Pharm Bull. 1999;22(11):1158–62.PubMedCrossRef
46.
go back to reference Shalabi H, Hassan IV, AS, AL-Zahrani FA, Alarbeidi AH, Mesawa M, Rizk H, Aljubayri AA, Alarbeidi IV AH, Aljubayri IV, A. A. (2023). Intermittent Fasting: Benefits, Side Effects, Quality of Life, and Knowledge of the Saudi Population. Cureus, 15(2). Shalabi H, Hassan IV, AS, AL-Zahrani FA, Alarbeidi AH, Mesawa M, Rizk H, Aljubayri AA, Alarbeidi IV AH, Aljubayri IV, A. A. (2023). Intermittent Fasting: Benefits, Side Effects, Quality of Life, and Knowledge of the Saudi Population. Cureus, 15(2).
48.
go back to reference Sutton EF, Beyl R, Early KS, Cefalu WT, Ravussin E, Peterson CM. Early time-restricted feeding improves insulin sensitivity, blood pressure, and oxidative stress even without weight loss in men with prediabetes. Cell Metab. 2018;27(6):1212–21.PubMedPubMedCentralCrossRef Sutton EF, Beyl R, Early KS, Cefalu WT, Ravussin E, Peterson CM. Early time-restricted feeding improves insulin sensitivity, blood pressure, and oxidative stress even without weight loss in men with prediabetes. Cell Metab. 2018;27(6):1212–21.PubMedPubMedCentralCrossRef
49.
go back to reference Tinsley GM, Forsse JS, Butler NK, Paoli A, Bane AA, La Bounty PM, Morgan GB, Grandjean PW. Time-restricted feeding in young men performing resistance training: a randomized controlled trial. Eur J Sport Sci. 2017;17(2):200–7.PubMedCrossRef Tinsley GM, Forsse JS, Butler NK, Paoli A, Bane AA, La Bounty PM, Morgan GB, Grandjean PW. Time-restricted feeding in young men performing resistance training: a randomized controlled trial. Eur J Sport Sci. 2017;17(2):200–7.PubMedCrossRef
50.
go back to reference Viikari LA, Huupponen RK, Viikari JSA, et al. Relationship between Leptin and C-Reactive Protein in Young Finnish Adults. J Clin Endocrinol Metab. 2007;92:4753–8.PubMedCrossRef Viikari LA, Huupponen RK, Viikari JSA, et al. Relationship between Leptin and C-Reactive Protein in Young Finnish Adults. J Clin Endocrinol Metab. 2007;92:4753–8.PubMedCrossRef
51.
52.
go back to reference Wilkinson MJ, Manoogian EN, Zadourian A, Lo H, Fakhouri S, Shoghi A, Wang X, Fleischer JG, Navlakha S, Panda S, Taub PR. Ten-hour time-restricted eating reduces weight, blood pressure, and atherogenic lipids in patients with metabolic syndrome. Cell Metab. 2020;31(1):92–104.PubMedCrossRef Wilkinson MJ, Manoogian EN, Zadourian A, Lo H, Fakhouri S, Shoghi A, Wang X, Fleischer JG, Navlakha S, Panda S, Taub PR. Ten-hour time-restricted eating reduces weight, blood pressure, and atherogenic lipids in patients with metabolic syndrome. Cell Metab. 2020;31(1):92–104.PubMedCrossRef
Metadata
Title
Effect of intermittent fasting on lipid biokinetics in obese and overweight patients with type 2 diabetes mellitus: prospective observational study
Authors
Yasmin Atwa Mohamed
Megahed Abouelmagd
Aya Elbialy
Mona Elwassefy
Fady Kyrillos
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2024
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/s13098-023-01234-3

Other articles of this Issue 1/2024

Diabetology & Metabolic Syndrome 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.